The Salesforce-backed business planning software producer has filed for a $100m initial public offering having raised $176m in VC funding.

Ericsson will exit big data software producer Cask, which has agreed to an acquisition of undisclosed size by Google.

Rocket Internet-backed e-commerce platform Home24 is seeking between $178 and $235m as it prepares to float on the Frankfurt Stock Exchange.

Intel Capital, Mastercard, American Express and Santander will all exit in the deal, which more than doubled iZettle's valuation in five months.

Kadmon remains the largest shareholder of gene therapy developer MeiraGTx, which has filed to raise up to $86.3m on the Nasdaq Global Market.

Polyphor, which has collaboration agreements in place with multiple pharmaceutical companies, raised $155m when it floated on the SIX Swiss Exchange.

Daily fantasy sports platform FanDuel is in talks to be acquired by Paddy Power Betfair, allowing Comcast, Time Warner and Alphabet to exit.

Baylor College of Medicine immuno-oncology spinout Marker Therapeutics is to merge with publicly-listed TapImmune, which has set up a $70m private placement to support the new entity.

Johnson & Johnson, Vactech and MacroGenics all own stakes in Provention they got through licensing drug candidates to the company.

Investors in M17, the owner of properties such as Paktor and 17 Media, include MCN, Yahoo Japan and LeSports.